We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Panel Unanimously Votes Down Pharmaxis’ Bronchitol
FDA Advisory Panel Unanimously Votes Down Pharmaxis’ Bronchitol
January 30, 2013
The FDA’s Pulmonary-Allergy Drugs Advisory Committee unanimously voted against recommending Pharmaxis’ cystic fibrosis (CF) drug Bronchitol for approval.